Table 1.
The mean and the Standard deviation of the 10-fold cross-validation error (in percentage) for the different approaches and the Affymetrix platform datasets employed in the study.
| Method | CNS | Colon | Leukemia | Prostate |
| Gene selection | mean ± std | mean ± std | mean ± std | mean ± std |
| U, SNR, NMC | 30.4 ± 6.5 * | 12.9 ± 4.2 * | 4.8 ± 2.7 * | 9.7 ± 4.2 * |
| U, SNR, FLD | 42.5 ± 7.3 | 19.2 ± 5.9 | 8.0 ± 3.2 | 10.0 ± 3.0 * |
| U, t-test, NMC | 32.5 ± 4.9 * | 12.5 ± 4.2 * | 4.8 ± 2.7 * | 10.8 ± 3.4 |
| U, t-test, FLD | 35.8 ± 6.5 * | 11.7 ± 3.5 * | 12.0 ± 4.2 | 8.0 ± 2.5 * |
| BP greedy, FLD | 43.8 ± 6.2 | 12.9 ± 3.8 * | 11.6 ± 3.6 | 9.8 ± 3.3 * |
| FS, FLD | 47.9 ± 5.1 | 15.4 ± 4.1 | 10.2 ± 4.2 | 14.0 ± 3.4 |
| RFE, FLD | 34.2 ± 5.0 * | 22.9 ± 4.4 | 3.5 ± 2.6 * | 10.0 ± 2.6 * |
| RFE, SVM | 35.4 ± 5.0 * | 22.1 ± 3.5 | 4.5 ± 2.6 * | 8.0 ± 2.9 * |
| Liknon | 32.9 ± 6.1 * | 13.3 ± 4.2 * | 11.8 ± 4.0 | 10.8 ± 3.7 |
| TSP | 47.0 ± 5.6 | 5.4 ± 2.9 * | 10.6 ± 3.8 | 7.0 ± 2.6 * |
| no gene selection | mean ± std | mean ± std | mean ± std | mean ± std |
| NMC | 42.1 ± 5.5 | 17.9 ± 3.3 | 3.5 ± 2.6 * | 33.7 ± 3.9 |
| FLD | 32.9 ± 6.3 * | 21.7 ± 3.7 | 4.5 ± 2.6 * | 8.0 ± 2.5 * |
| SVM | 35.4 ± 7.0 * | 22.1 ± 3.5 | 3.5 ± 2.6 * | 8.0 ± 2.9 * |